Acute Porphyria Drug Database

Monograph

R03BC01 - Cromoglicic Acid
Not porphyrinogenic
NP

Rationale
Not metabolised.
Chemical description
Antiinflammatory drug used in local treatment (nasal spray 2,6 -5,2 mg/dose) of allergic rhinitis. Excreted in unchanged form. South African list: use. C.Andersson, patient reports: tolerated (n=1)
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes R03B / R03BC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Cromogen · Cromogen 20mg/2ml nebuliser liquid Steri-Neb unit dose vials · Cromogen 5mg/dose Easi-Breathe inhaler · Cromogen 5mg/dose inhaler · Cromosol · Cromosol 20mg/2ml nebuliser liquid unit dose vials · Intal · Intal 20mg Spincaps · Intal 20mg/2ml nebuliser solution unit dose vials · Intal 5mg/dose Fisonair with spacer · Intal 5mg/dose inhaler · Intal 5mg/dose inhaler CFC free · Intal 5mg/dose Syncroner with spacer · Intal Fisonair 5mg/actuation inhaler with spacer · Sodium cromoglicate · Sodium cromoglicate 20mg/2ml nebuliser liquid unit dose vials · Sodium cromoglicate 5mg/dose inhaler · Sodium cromoglicate 5mg/dose inhaler CFC free
Finland
Lomudal
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙